PE20000472A1 - Compuestos triciclicos sustituidos - Google Patents

Compuestos triciclicos sustituidos

Info

Publication number
PE20000472A1
PE20000472A1 PE1999000321A PE00032199A PE20000472A1 PE 20000472 A1 PE20000472 A1 PE 20000472A1 PE 1999000321 A PE1999000321 A PE 1999000321A PE 00032199 A PE00032199 A PE 00032199A PE 20000472 A1 PE20000472 A1 PE 20000472A1
Authority
PE
Peru
Prior art keywords
phenyl
conh2
pyridyl
interfering
substitute
Prior art date
Application number
PE1999000321A
Other languages
English (en)
Spanish (es)
Inventor
David Mihelich Edward
Suarez Tulio
C R Smith Edward
Michael Morin Junior John
Wang Qiuping
James Bach Nicholas
Dean Kinnick Michael
Scott Sawyer Jason
Jon Sall Daniel
John Martinelli Michael
Michael Wilson Thomas
Wade Beight Douglas
Anne Bastian Jolie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20000472A1 publication Critical patent/PE20000472A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
PE1999000321A 1998-04-17 1999-04-16 Compuestos triciclicos sustituidos PE20000472A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6216598A 1998-04-17 1998-04-17

Publications (1)

Publication Number Publication Date
PE20000472A1 true PE20000472A1 (es) 2000-06-02

Family

ID=22040624

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000321A PE20000472A1 (es) 1998-04-17 1999-04-16 Compuestos triciclicos sustituidos

Country Status (27)

Country Link
EP (2) EP0950661B1 (https=)
JP (1) JP4435325B2 (https=)
KR (1) KR19990083234A (https=)
CN (1) CN1235968A (https=)
AR (1) AR018185A1 (https=)
AT (2) ATE259818T1 (https=)
AU (1) AU757454B2 (https=)
BR (1) BR9901275A (https=)
CA (1) CA2269256A1 (https=)
CO (1) CO5080728A1 (https=)
CZ (1) CZ137199A3 (https=)
DE (2) DE69912670T2 (https=)
EA (1) EA003129B1 (https=)
ES (2) ES2213668T3 (https=)
HU (1) HUP9901219A1 (https=)
ID (1) ID23219A (https=)
IL (1) IL129484A0 (https=)
NO (1) NO991823L (https=)
NZ (1) NZ335252A (https=)
PE (1) PE20000472A1 (https=)
PL (1) PL332564A1 (https=)
SG (1) SG106035A1 (https=)
SV (1) SV1999000052A (https=)
TR (1) TR199900842A2 (https=)
TW (1) TW555760B (https=)
YU (1) YU19099A (https=)
ZA (1) ZA992773B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513555A (ja) * 1997-08-28 2001-09-04 イーライ・リリー・アンド・カンパニー 非リウマチ様関節炎の処置方法
AU2001244635A1 (en) * 2000-03-30 2001-10-15 Yamanouchi Pharmaceutical Co..Ltd. Hydrazide derivatives
CN1450893A (zh) * 2000-07-14 2003-10-22 伊莱利利公司 治疗脓毒症的方法
ES2264708T3 (es) * 2000-12-18 2007-01-16 Eli Lilly And Company Derivados tetraciclicos como inhibidores de la spla2.
JP2004525154A (ja) * 2001-03-28 2004-08-19 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしての置換カルバゾール
US7160909B2 (en) 2001-08-09 2007-01-09 Eli Lilly And Company Cyclopenta[b]indole derivatives as sPLA2 inhibitors
ATE312817T1 (de) 2001-08-09 2005-12-15 Lilly Co Eli Cyclohept'bö indolderivate als spla2-inhibitoren
US6992100B2 (en) 2001-12-06 2006-01-31 Eli Lilly And Company sPLA2 inhibitors
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
KR101614723B1 (ko) 2008-01-11 2016-04-22 알바니 몰레큘라 리써치, 인크. Mch 길항물질로서 (1-아지논)-치환된 피리도인돌
US9073925B2 (en) 2009-07-01 2015-07-07 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
DK2697223T3 (en) * 2011-04-14 2016-09-05 Actelion Pharmaceuticals Ltd 7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor
CN104203951B (zh) 2012-03-16 2016-11-02 生命医药公司 肝x受体调节剂
WO2013138568A1 (en) 2012-03-16 2013-09-19 Vitae Pharmaceuticals, Inc. Liver x reception modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3979391A (en) * 1972-11-22 1976-09-07 Sterling Drug Inc. 1,2,3,4-Tetrahydrocarbazoles
PT95692A (pt) * 1989-10-27 1991-09-13 American Home Prod Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
IL109309A (en) * 1993-04-16 2000-06-29 Lilly Co Eli 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
JPH10505584A (ja) * 1994-07-21 1998-06-02 イーライ・リリー・アンド・カンパニー インドリジンsPLA▲下2▼インヒビター
AU1289797A (en) * 1995-12-13 1997-07-03 Eli Lilly And Company Naphthyl acetamides as spla2 inhibitors
JP2001503055A (ja) * 1996-10-30 2001-03-06 イーライ・リリー・アンド・カンパニー 置換三環化合物群
AU9664198A (en) * 1997-09-26 1999-04-23 Eli Lilly And Company Method for the treatment of cystic fibrosis
CA2310250A1 (en) * 1997-11-14 1999-05-27 August Masaru Watanabe Treatment for alzheimer's disease

Also Published As

Publication number Publication date
ES2210979T3 (es) 2004-07-01
AR018185A1 (es) 2001-10-31
NO991823D0 (no) 1999-04-16
EA003129B1 (ru) 2003-02-27
NO991823L (no) 1999-10-18
YU19099A (sh) 2001-09-28
HUP9901219A1 (hu) 2000-08-28
CN1235968A (zh) 1999-11-24
ATE254128T1 (de) 2003-11-15
HU9901219D0 (en) 1999-06-28
EP0950661A1 (en) 1999-10-20
PL332564A1 (en) 1999-10-25
SV1999000052A (es) 2000-03-14
AU757454B2 (en) 2003-02-20
EA199900304A2 (ru) 1999-10-28
ATE259818T1 (de) 2004-03-15
EP1156050B1 (en) 2004-02-18
EP1156050A3 (en) 2001-11-28
KR19990083234A (ko) 1999-11-25
CO5080728A1 (es) 2001-09-25
TR199900842A2 (xx) 2000-09-21
DE69914951D1 (de) 2004-03-25
AU2381899A (en) 1999-10-28
CA2269256A1 (en) 1999-10-17
EP0950661B1 (en) 2003-11-12
TW555760B (en) 2003-10-01
ES2213668T3 (es) 2004-09-01
IL129484A0 (en) 2000-02-29
EP1156050A2 (en) 2001-11-21
DE69914951T2 (de) 2004-12-23
ZA992773B (en) 2002-07-16
NZ335252A (en) 2000-11-24
BR9901275A (pt) 2000-05-02
JPH11322745A (ja) 1999-11-24
SG106035A1 (en) 2004-09-30
DE69912670T2 (de) 2004-08-12
ID23219A (id) 2000-03-30
EA199900304A3 (ru) 2000-04-24
JP4435325B2 (ja) 2010-03-17
DE69912670D1 (de) 2003-12-18
CZ137199A3 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
PE20000472A1 (es) Compuestos triciclicos sustituidos
PE20000476A1 (es) Compuestos triciclicos sustituidos
MX9800882A (es) Lubricantes transportadores de alquil eter amina que contienen inhibidores de corrosion.
AU584428B2 (en) (Meth) -Acrylic acid esters and the use thereof
DE69728298D1 (de) Quarternäre fettsäure-triethanolamin-estersalze und ihre verwendung als weichmacher von geweben
ATE513895T1 (de) Schmieren eine cvt übertragung mit einer kraftübertragungsflüssigkeit
ES2126697T3 (es) Inhibidores de enzimas de conversion de angiotensina que contienen lactamas de anillos multiples.
DE69228627D1 (de) Langkettiger Carbonsäureimidester
DE60332350D1 (de) Disazofarbstoffe und sie enthaltende tintenstrahldrucktinten
ATE137805T1 (de) Verfahren zur erhöhung von chemilumineszenz
DK0915851T3 (da) Dibenzodihydropyridincarboxyl-estre og deres anvendelse i kemiluminiscens-analyse-fremgangsmåder
DE3876336D1 (de) Schmieroelzusammensetzungen mit multifunktionellen zusatzkomponenten.
DE69007664D1 (de) Detergent, Dispersant und Antikorrosionszusätze für Kraftstoffe und Schmieröle.
NO942757D0 (no) 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-okso-kinolin-derivater
GB9007338D0 (en) Chemical compounds
BR8606955A (pt) Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel
DE69012434D1 (de) Carbonsäureester und deren Anwendung in Flüssigkristallzusammensetzungen.
FI911460A0 (fi) Tillsatsaemnen foer smoerjolja samt deras framstaellning och anvaendning.
DK297388A (da) Smoereoliesammensaetning med indhold af antislid/hoejtryksadditiver
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
ES2137559T3 (es) Inhibidores de las metaloproteinasas de la matriz basados en acido malonico.
CO5210989A1 (es) Composicion blanqueadora que comprende un acido peroxicarboxilico preformado y un sistema surfactante que comprende por lo menos dos surfactantes
PL173830B1 (pl) Koncentrat dodatków
KR830002766A (ko) 옥사졸리노 아제티디논의 제조방법
PL172886B1 (pl) Koncentrat dodatków do olejów hydraulicznych PL

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed